Pharmacy Hit With NJ Suit Over GLP-1 Marketing
A compounding pharmacy deceptively and falsely marketed its GLP-1 compounded weight loss medications as safe, effective, clinically supported and personalized, according to a proposed class action filed in New Jersey federal...To view the full article, register now.
Already a subscriber? Click here to view full article